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Summary
Background: The usefulness of distress screening in can-
cer inpatient settings has rarely been investigated. This 
study evaluated a brief distress screening of inpatients in 
a breast cancer centre and a gynaecological cancer cen-
tre. Patients and Methods: Hospitalised patients with 
breast or gynaecological cancers were screened with 
the Distress Thermometer. Patients who scored above 
the cut-off, were referred by the medical staff, or self- 
referred were offered bedside psycho-oncological coun-
selling. Results: Of 125 patients, 68 (54.4%) received an 
offer of counselling, and 62 patients (49.6%) accepted. 
Most of the counselling was induced by distress screen-
ing. Only 4 (3.2%) patients self-referred to the counsel-
ling service. Of the counselled patients, 65.8% stated that 
they had substantially benefited from psycho-oncologi-
cal support; only 5.6% of the non-counselled patients 
 indicated that they might have benefited from psycho-
oncological support. Conclusion: Almost all patients who 
will accept and benefit from psycho-oncological counsel-
ling can be identified if distress screening is used in con-
junction with referrals by physicians and nurses. Distress 
screening is a worthwhile component in a framework of 
psycho-oncological support in a cancer inpatient setting. 
It paves the way to counselling for cancer inpatients who 
need it and are willing to accept it but hesitate to self- 
refer to psycho-oncological services.
Introduction
There is no doubt that cancer and cancer therapy can im­
pose an immense psychological burden on affected individu­
als. The severe emotional distress many cancer patients suffer 
often remains unnoticed and thus untreated [1]. Screening for 
distress has therefore been recognized as an important issue 
in oncology care [2]. While a growing body of research has 
investigated the impact of distress screening in cancer out­
patient settings [3–8], research on distress screening in cancer 
inpatients has only just begun. Evidence of particularly high 
levels of emotional distress [9, 10] and high rates of mental 
disorders [11] in hospitalised cancer patients suggests that 
 distress screening may be especially relevant in an inpatient 
setting. In an Australian study, distress screening increased 
 inpatient referrals to psychosocial services [12].
Screening is not necessarily useful, even if valid screening 
tools are used [13]. Patients who are correctly identified as 
highly distressed may still not get help, and even if psychologi­
cal support is available for these patients, they may not accept 
it [3]. Conversely, less distressed patients may want psycho­
logical support [6, 14] and benefit from it as a preventative 
measure. Distress and acceptance of psychological support 
have been found to be modestly [13, 15–18] or not at all [3, 6, 
19] correlated. For this reason, we did not intend to validate a 
screening instrument against a more elaborate measurement 
of psychological state but to explore whether a brief, easily 
feasible screening is useful in clinical practice. Taking into ac­
count the fact that in practice, screening is never the only 
pathway to psycho­oncological counselling, we deliberated 
that distress screening should be considered useful if the 
 following criteria were met: i) a combination of referrals from 
the medical staff, patient self­referrals, and distress screening 
should identify almost all patients who accept counselling and 
benefit from it; ii) a substantial proportion of these patients 
should be identified exclusively by distress screening; and 
iii) distress screening should not induce counselling in a 
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 assessment before discharge. The Distress Thermometer was applied 
again. The Hospital Anxiety and Depression Scale (HADS) [27], a well­
established 14­item questionnaire created to measure depression and 
anxiety in somatically ill patients, was administered. Additionally, coun­
selled patients, i.e. patients who had received at least 10 min of counsel­
ling, were asked whether the counselling had been dispensable, rather 
less important, important, or very important to them. The patients who 
rated the counselling as important or very important were considered to 
 substantial number of patients who do not benefit from it. 
Further, we wanted to explore how many patients are selected 
for psycho­oncological counselling if distress screening is 
used, and how many of these patients accept counselling and 
receive it. We investigated these questions in the breast can­
cer centre and the gynaecological cancer centre of our univer­
sity hospital. In both centres, screening with the Distress 
Thermometer is a long­standing clinical routine. 
Patients and Methods
All patients passed through the usual screening and counselling rou­
tines established in our hospital. Patient data und data on screening and 
counselling were routinely recorded. Shortly before discharge, an assess­
ment of eligible patients was added for the study (fig. 1). The assessment 
included a brief interview to determine actual benefit in patients who had 
received counselling, and potential benefit from counselling in those who 
had not received it. Actual benefit and potential benefit from counselling 
were conceptualised as patient­perceived actual benefit and patient­pre­
sumed potential benefit, respectively. We were confident that counselled 
patients could best appraise actual benefit themselves. Even though the 
non­counselled patients’ expectations of counselling benefits may be less 
correct, it is unlikely that patients who do not expect to benefit from 
counselling would even have accepted it. To complement the patients’ ap­
praisals, we additionally assessed the course of distress and emotional 
state at discharge. We then determined whether patients who potentially 
could have benefited from counselling had been overlooked in spite of 
screening. We further determined how many patients had received coun­
selling exclusively because of screening – without a referral or self­refer­
ral – and benefited from it, and how many patients had been counselled 
without benefit.
Procedure
Following our clinical routine, all patients were handed the Distress 
Thermometer upon admission by a nurse. To not increase the nurses’ 
workload, return of the filled­in Distress Thermometer forms was left up 
to the patients. The forms were then forwarded to 2 onsite clinical psy­
chologists who personally offered psycho­oncological counselling to all 
patients who scored 5 or more on the 0–10­point Distress Thermometer 
analogue scale or indicated 2 or more of 5 emotional problems (worry, 
fears, sadness, depression, and nervousness) on the adjunct problem list. 
These cut­off scores were chosen based on reported observations in Ger­
man cancer patients [20]. In addition to screening, physicians and nurses 
referred patients in need of counselling to the psychologists, and the pa­
tients were made aware of the opportunity to self­refer to the counselling 
service. Counselling differed in number and length of sessions and in­
cluded psycho­educational and supportive elements according to the 
 patients’ individual needs. Counselling was either covered by insurance or 
free. Whenever a clinician who was involved with the study was available 
at the time of a patient’s discharge, this patient, if eligible, was asked to 
participate in a brief assessment. 
Assessments
The Distress Thermometer, a widely­used and well­validated self­ 
report screening tool [2, 16, 18, 20–26], consists of 2 sections, the 11­point 
distress scale featured as a thermometer, and the Problem List that speci­
fies potential sources of distress. Distress Thermometer screening results, 
offers of counselling, acceptance of counselling, length of counselling 
 sessions (for descriptive purposes), the pathway that had induced coun­
selling, and basic demographic and medical data were recorded for all 
 patients (fig. 1). Additional demographic data were collected at the Fig. 1. Flow chart of study proceedings.
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have benefited from the counselling. Non­counselled patients were asked 
whether they thought that psychological support would have been dispen­
sable, rather less important, important, or very important to them. Pa­
tients who rated counselling as important or very important were consid­
ered to potentially have benefited from it. These patients were asked 
whether they had known about the opportunity to self­refer to the coun­
selling service, and if they answered in the affirmative, they were asked 
why they had not made use of it. The assessments were conducted by 1 of 
3 physicians, 2 clinical psychologists, or a psychology student. To avoid 
response bias, none of the patients were assessed by the psychologist who 
had counselled her.
Patients
All patients who had been treated for breast cancer or for invasive 
gynaecological cancers of any stage during a specified period of 15 weeks 
and had stayed for at least 2 nights at the Munich University Hospital 
(Campus Grosshadern) were included. To be further eligible for assess­
ment at discharge, patients needed to speak sufficient German or English 
and give written informed consent. The study was approved by the ethics 
committee of the University of Munich.
Statistical Analyses
T­tests and chi­square tests were used. All analyses were carried out 
with the Statistical Package for the Social Sciences, SPSS versions 19 and 
20 (IBM Corp., Armonk, NY, USA). Statistical tests were 2­sided, and 
significance was calculated with a 5% type I error.
Results
During the specified period, 125 cancer patients (breast 
cancer n = 71, gynaecological cancer n = 54) had stayed at 
least 2 nights at the hospital. The data of these patients were 
included in the analysis (fig. 1). 69 (55.2%) patients had at 
least partially filled in the Distress Thermometer and returned 
it. Of all 125 patients, 68 (54.4%) were offered counselling, 
and 62 accepted the offer and received counselling (91.2% of 
the approached patients and 49.6% of all patients). None 
of these rates differed significantly between breast cancer 
 patients and patients with gynaecological cancers. Of the 
 patients who received counselling, 24 had been referred by 
physicians or nurses, 4 had self­referred, 10 were counselled 
for miscellaneous causes (they had already been known to the 
counsellors, the counsellors were alerted by fellow patients, or 
the counsellors had accidentally noticed the patient’s need of 
counselling), and 43 were identified by screening. Counselling 
could be induced by more than 1 pathway, and these groups 
therefore overlap. 30 patients were not referred or otherwise 
selected for counselling but were counselled exclusively be­
cause of screening (48.4% of all counselling cases and 24.0% 
of all patients). 68 patients were invited to be assessed shortly 
before discharge. Of these, 6 declined, 2 had language prob­
lems, and 60 participated in the assessment. Patients who 
were assessed at the time of discharge did not differ signifi­
cantly from non­assessed patients regarding age, diagnosis, 
length of hospital stay, Distress Thermometer score at admis­
sion, and number of emotional problems at admission. More 
assessed than non­assessed patients had received personal of­
fers of counselling and had been counselled (table 1).




at discharge (n = 60)
Patients not assessed 
at discharge (n = 65)
p
Age, mean (SD), years 60.4 (12.8) 59.4 (12.6) 61.4 (12.9) 0.391
Relationship status, n (%) –
In domestic partnership – 41 (68.3) –
Single – 19 (31.7) –
Educational level, n (%) –
Low – 18 (30.0) –
Medium – 21 (35.0) –
High – 21 (35.0) –
Diagnosis, n (%) 0.696
Breast cancer 71 (56.8) 33 (55.0) 38 (58.5)
Gynaecological cancer 54 (43.2) 27 (45.0) 27 (41.5)
Length of hospital stay, mean (SD), days  7.8 (5.9)  8.0 (5.0)  7.7 (6.7) 0.741
Distress Thermometer score at admission, mean (SD)  5.7 (2.8) 
n = 62
 6.0 (2.8) 
n = 36
 5.3 (2.7) 
n = 26
0.371
Emotional problems indicated on Distress Thermometer  
at admission, mean (SD), n
 1.9 (1.7) 
n = 69
 2.3 (1.6) 
n = 40
 1.5 (1.8) 
n = 29
0.068
Counselling offered, n (%) 68 (54.4) 44 (73.3) 24 (36.9) 0.001
Counselling received, n (%) 62 (49.6) 41 (68.3) 21 (32.3) 0.001
Counselling time per counselled patient (total of all sessions), n (%) 0.347
10–30 min 20 (32.8) 14 (35.0)  6 (28.6)
31–60 min 21 (34.4) 15 (37.5)  6 (28.6)
60–90 min 11 (18.0)  6 (15.0)  5 (23.8)
90–120 min  5 (8.2)  4 (10.0)  1 (4.8)
> 120 min  4 (6.6)  1 (2.5)  3 (14.3)
SD = Standard deviation.
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Even though only little more than half of the patients had 
participated in the distress screening, most counselling was 
prompted by screening. Almost half of the counselled patients 
had not been referred by the medical staff but were offered 
counselling based exclusively on distress screening. Very 
few patients self­referred. Evidently, the patients preferred 
to communicate their counselling needs through the screen­
ing instrument and to be subsequently approached by a 
counsellor. 
Two­thirds of the counselled patients reported considera­
ble benefit from the psycho­oncological support. The lack of 
substantial benefit from counselling that was reported by the 
remaining third of counselled patients may be partially due to 
the failure of screening and partially to unsuccessful counsel­
ling. Overall, counselled patients showed reduced distress at 
discharge, which was not observed in the non­counselled 
patients.
Very few patients who could have benefited from counsel­
ling had been overlooked. Only 1 of 19 non­counselled pa­
tients who were assessed at discharge declared that counsel­
ling might have been important. The non­counselled patients’ 
view that counselling had not been necessary for them was 
corroborated by the finding that these patients’ emotional 
state at discharge was significantly better than that of coun­
selled patients. Initially low distress levels in this group had 
only minimally risen. The non­counselled patients had obvi­
ously fared well without counselling. 
Because of the high rate of patients who benefited from 
counselling but would have been missed without screening, 
distress screening for hospitalised cancer patients must be rec­
ommended. Obviously, screening gives patients the chance to 
communicate their emotional state without having to openly 
admit their need of psycho­oncological counselling. Distress 
screening thus lowers the threshold to counselling. 
Our study has several limitations. In this unfunded investi­
gation, benefit and potential benefit from counselling and 
thus, implicitly, benefit from screening could only be assessed 
in a subgroup of patients that was small (n = 60), albeit not 
different from the entire patient sample regarding basic de­
mographic and medical characteristics. Moreover, because 
data were collected under practice conditions, many data on 
the patients’ distress at admission to hospital are missing. In 
particular, many patients who regarded counselling as not 
 important chose not to return the Distress Thermometer, and, 
accordingly, most of these patients did not receive counsel­
ling. The finding that the non­counselled patients had low 
 distress levels at admission has therefore to be regarded 
as tentative. These patients, however, clearly showed low 
 distress at discharge, which confirms that they had not needed 
counselling. Further, benefit from counselling was largely de­
termined by the patients’ subjective appraisals. The results of 
our study are only applicable if a qualified psycho­oncological 
service can promptly provide counselling to patients with 
 positive screening results.
Counselled Patients: Assessment of Benefit  
from Counselling
Of the 41 counselled patients who were asked how impor­
tant psycho­oncological counselling had been to them, the 
 answers of 3 patients could not be coded. Of the remaining 38 
patients, 25 (65.8%) stated that the psychological support had 
been important (n = 15) or very important (n = 10) to them. 
11 (44%) of these patients had been detected exclusively by 
screening. 13 (34.2%) patients rated the psychological support 
as less important (n = 8) or dispensable (n = 5). Comparison 
of Distress Thermometer scores at admission (mean 6.6, 
standard deviation (SD) 2.6, n = 30) and at discharge (mean 
4.7, SD 2.8, n = 38) showed a significant reduction in distress 
in counselled patients (paired t­test: p = 0.014, n = 28). The 
mean HADS score of counselled patients at discharge was 
13.2 (SD 7.2, n = 39).
Non-Counselled Patients: Assessment of Potential  
Benefit from Counselling
Of the 19 non­counselled patients who were asked whether 
psycho­oncological counselling might have been important, 
1 patient could not decide; of the 18 remaining patients, 17 
(94.4%) rated counselling either as dispensable (n = 10) or as 
less important (n = 7), and 1 patient said that counselling 
would have been important to her. She stated that she had 
known of the opportunity to self­refer to the counselling 
 service but had been too busy to use it. No reduction in 
 distress was observed in the non­counselled patients (Distress 
Thermometer score at admission, mean 3.0, SD 1.8, n = 6; 
at discharge, mean 3.6, SD 2.2, n = 17). Non­counselled pa­
tients scored significantly lower in the HADS at discharge 
(mean 7.6, SD 5.4, n = 18) than counselled patients (see 
above; p = 0.005).
Discussion
We evaluated the usefulness of distress screening under 
practice conditions in an inpatient setting. To obtain a truthful 
picture, the patients underwent the usual screening and coun­
selling routines that are established in our hospital. About half 
of all patients who stayed at our centres for breast and gynae­
cological cancers for at least 2 nights received  personal offers 
of bedside psycho­oncological counselling.  Offers were ac­
cepted by more than 90% of the approached patients, a rate 
that far exceeds acceptance rates observed in outpatient 
 samples [3–6, 16, 28]. There may be several reasons for this 
 divergence: hospitalised cancer patients have been found to 
suffer from particularly severe distress [9, 10]; bedside coun­
selling means less expenditure of time and effort than appoint­
ments at external psycho­oncology services, a point that may 
be particularly relevant for cancer patients many of whom are 
frail; and moreover, personal invitations by the counsellors 
themselves may lower the threshold for counselling.
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cal work at no costs and with minimal effort for staff and 
 patients. However, there is a downside to distress screening: a 
minority of patients with positive screening results will accept 
counselling but not benefit from it. We doubt that more valid 
screening can resolve this issue. Counsellors should be aware 
that a proportion of patients does not benefit from counsel­
ling notwithstanding positive screening results.
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Our study demonstrated that nearly all hospitalised pa­
tients with breast or gynaecological cancers, who potentially 
benefit from psycho­oncological counselling, can be identified 
if a brief distress screening is used in combination with nurses’ 
and physicians’ observations of the patients’ needs. If positive 
screening results are followed up by personal offers of coun­
selling from the counsellors themselves, screening paves the 
way to psycho­oncological support for many cancer inpatients 
who refrain from self­referral but still want counselling and 
benefit from it. Distress screening gives these patients the 
 opportunity to noncommittally communicate their counselling 
needs. Brief distress screening can be integrated into the clini­
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